Zealand Pharma AS (XTER:22Z)
€ 41.21 (0%) Market Cap: 2.76 Bil Enterprise Value: 877.33 Mil PE Ratio: 7.80 PB Ratio: 1.16 GF Score: 45/100

Q1 2026 Zealand Pharma A/S Earnings Call Transcript

May 07, 2026 / 12:00PM GMT
Operator

Good day. Thank you for standing by. Welcome to the Zealand Pharma Results for Q1 2026 conference call. (Operator Instructions) Please be advised that this conference is being recorded.

I would now like to hand the conference over to your speaker today, Eric Rojas, Vice President and Head of Investor Relations. Please go ahead.

Eric Rojas;S;Vice President and Head of Investor Relations
Zealand Pharma A

/-

Thank you, operator. Thank you to everyone for joining us today to discuss Zealand Pharma's results for the first quarter of 2026. This is Eric Rojas. I recently joined Zealand Pharma as Vice President and Head of Investor Relations. I'm pleased to be with the team today in Denmark to get the conference call started. I look forward to working with all of you. The related company announcement for Q1 2026 is available on our website at zealandpharma.com.

As outlined on the slide, I would like to remind listeners that during today's call, we will be making forward-looking statements that are subject to risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot